These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26616211)

  • 1. Current disease modifying approaches to treat Parkinson's disease.
    Lindholm D; Mäkelä J; Di Liberto V; Mudò G; Belluardo N; Eriksson O; Saarma M
    Cell Mol Life Sci; 2016 Apr; 73(7):1365-79. PubMed ID: 26616211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism.
    Lindholm P; Saarma M
    Mol Psychiatry; 2022 Mar; 27(3):1310-1321. PubMed ID: 34907395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
    Voutilainen MH; Arumäe U; Airavaara M; Saarma M
    FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDNF Protein Therapy in Parkinson's Disease.
    Huttunen HJ; Saarma M
    Cell Transplant; 2019 Apr; 28(4):349-366. PubMed ID: 30947516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
    Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
    Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease.
    Er S; Airavaara M
    Biochem Soc Trans; 2023 Feb; 51(1):245-257. PubMed ID: 36794783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
    Barker RA; Björklund A; Gash DM; Whone A; Van Laar A; Kordower JH; Bankiewicz K; Kieburtz K; Saarma M; Booms S; Huttunen HJ; Kells AP; Fiandaca MS; Stoessl AJ; Eidelberg D; Federoff H; Voutilainen MH; Dexter DT; Eberling J; Brundin P; Isaacs L; Mursaleen L; Bresolin E; Carroll C; Coles A; Fiske B; Matthews H; Lungu C; Wyse RK; Stott S; Lang AE
    J Parkinsons Dis; 2020; 10(3):875-891. PubMed ID: 32508331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.
    Petrova P; Raibekas A; Pevsner J; Vigo N; Anafi M; Moore MK; Peaire AE; Shridhar V; Smith DI; Kelly J; Durocher Y; Commissiong JW
    J Mol Neurosci; 2003 Apr; 20(2):173-88. PubMed ID: 12794311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.
    Domanskyi A; Saarma M; Airavaara M
    Hum Gene Ther; 2015 Aug; 26(8):550-9. PubMed ID: 26176331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial cell line-derived neurotrophic factor receptor Rearranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo.
    Mahato AK; Kopra J; Renko JM; Visnapuu T; Korhonen I; Pulkkinen N; Bespalov MM; Domanskyi A; Ronken E; Piepponen TP; Voutilainen MH; Tuominen RK; Karelson M; Sidorova YA; Saarma M
    Mov Disord; 2020 Feb; 35(2):245-255. PubMed ID: 31840869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic factors hold promise for the future of Parkinson's disease treatment: is there a light at the end of the tunnel?
    Nasrolahi A; Mahmoudi J; Akbarzadeh A; Karimipour M; Sadigh-Eteghad S; Salehi R; Farhoudi M
    Rev Neurosci; 2018 Jul; 29(5):475-489. PubMed ID: 29305570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson's disease.
    Yang C; Gao Y
    Front Biosci (Landmark Ed); 2020 Jun; 25(9):1718-1731. PubMed ID: 32472754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Dopamine Neurotrophic Factor: A Potential Therapeutic Agent for Parkinson's Disease.
    Tang T; Li Y; Jiao Q; Du X; Jiang H
    Neurosci Bull; 2017 Oct; 33(5):568-575. PubMed ID: 28337696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurorestoration.
    Airavaara M; Voutilainen MH; Wang Y; Hoffer B
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1(0 1):S143-6. PubMed ID: 22166416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential.
    Lindahl M; Saarma M; Lindholm P
    Neurobiol Dis; 2017 Jan; 97(Pt B):90-102. PubMed ID: 27425895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons.
    Kim GJ; Mo H; Liu H; Wu Z; Chen S; Zheng J; Zhao X; Nucum D; Shortland J; Peng L; Elepano M; Tang B; Olson S; Paras N; Li H; Renslo AR; Arkin MR; Huang B; Lu B; Sirota M; Guo S
    Elife; 2021 Sep; 10():. PubMed ID: 34550070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.
    Drinkut A; Tereshchenko Y; Schulz JB; Bähr M; Kügler S
    Mol Ther; 2012 Mar; 20(3):534-43. PubMed ID: 22086235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.